We rank companies based on fund manager, research analyst and news sentiment
BBP

Virtus LifeSci Biotech Products ETF
BBP

$51.69
1.12%
0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

42% more capital invested

Capital invested by funds: $1.94M [Q3] → $2.74M (+$805K) [Q4]

10% more funds holding

Funds holding: 10 [Q3] → 11 (+1) [Q4]

2.83% more ownership

Funds ownership: 12.89% [Q3] → 15.73% (+2.83%) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Research analyst outlook

We haven’t received any recent analyst ratings for BBP.

Financial journalist opinion